Description
Book SynopsisThe clinical management of patients with diabetes is rapidly evolving. This book provides a succinct summary of a range of topics, including areas where there is already well developed evidence for a particular treatment, but also those areas where the evidence is perhaps doubtful or there is some associated controversy or ambiguity. Where possible throughout the book treatment recommendations are given based on the available evidence and practice guidelines. The book also highlights the gaps in evidence where further research is needed. In the practice of diabetes care, there are many issues influencing practitioners currently. This book addresses many of the most pertinent issues concerning delivery of diabetes care such as: Is diabetes preventable in high-risk individuals? Once diabetes has developed what are the goals of treatment and how aggressive should treatment be whilst avoiding adverse effects? What is the role of treating glycaemia in reducing macrovascular disease? Who to screen, how to screen and who to treat for coronary artery disease? Who and how to treat hyperglycaemia in acute coronary syndromes? Has there been any progress in the management of gestational diabetes? Is there an evidence base for the treatment of Type 2 diabetes with oral hypoglycaemic agents? The authors are internationally renowned experts in the field of diabetes care who successfully and succinctly present state-of-the-art reviews based on the medical evidence designed to help the clinician be as best informed as possible in the care of patients with diabetes.
Table of ContentsInsulin resistance; Goals of treatment; Prevention of diabetes in high-risk individuals; Early insulin initiation in type 2 diabetes; Treatment of blood pressure; Glucose control & macrovascular disease/morbidity; Dual blockade of RAS in diabetes with ACE inhibitors & ARBs; Anaemia & renal disease; Treatment of foot conditions; Coronary artery disease: who to screen, how to screen, when to treat; Hyperglycaemia in patients with acute coronary syndromes; Gestational diabetes; Patient education; Drugs & outcomes; The role of CGMS in the management of type 1 & 2 diabetes; Retinopathy treatment; Neuropathy.
